TRIPLE RECEPTOR AGONIST PEPTIDE

RETATRIDE

RETATRUTIDE · 10 MG

Retatride™ is retatrutide, a synthetic peptide engineered to act on three incretin-related receptors — GIP, GLP-1 and glucagon. Supplied as lyophilised powder in vials of 10 mg, packed 10 vials per foil sachet for wholesale distribution.

REQUEST QUOTATION VIEW SPECIFICATIONS
FOR EXPORT ONLY FOR RESEARCH AND ANALYTICS ONLY
Retatride sachet label

ABOUT RETATRIDE

One peptide, three incretin-related receptor targets

Retatride™ is retatrutide, a synthetic peptide built on a modified GIP backbone with engineered activity at the GIP, GLP-1 and glucagon receptors. This triple-agonist profile has made it one of the most closely studied peptides in current metabolic research.

Retatride™ is supplied as a defined, batch-documented reference material for research and analytical applications, with identity and purity verified on every lot.

RECEPTOR TARGETS

10 MG

PER VIAL

2–8°C

COLD CHAIN

DNA helix

RESEARCH BACKGROUND

A peptide with a published clinical evidence base

Retatrutide (LY3437943) is the subject of a landmark phase 2, double-blind, randomised, placebo-controlled trial published in the New England Journal of Medicine. In adults with obesity, once-weekly retatrutide at the 12 mg dose produced a mean body-weight reduction of 24.2% after 48 weeks — with the weight-reduction curve not yet at a plateau when treatment ended.

A companion substudy published in Nature Medicine reported liver-fat reductions of more than 80% from baseline at the 8 mg and 12 mg doses in participants with metabolic dysfunction–associated steatotic liver disease. Phase 3 evaluation continues under the TRIUMPH programme.

PRIMARY REFERENCE

Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514–526.

ClinicalTrials.gov: NCT04881760

DOI: 10.1056/NEJMOA2301972

Reference provided for scientific context only. Retatride™ is analytical grade, for research and analytics only, and is not a medicinal product. CoreyPauling is not affiliated with the cited study or its sponsor.

PRODUCT SPECIFICATIONS

Retatride™ at a glance

Product name Retatride™
Active substance Retatrutide (synthetic peptide, GIP / GLP-1 / glucagon triple receptor agonist)
Strength 10 mg per vial
Form Lyophilised powder for reconstitution
Presentation Multi-dose glass vial
Pack size 10 vials per foil sachet
Origin Synthetic peptide built on a modified GIP backbone
Storage Store cold at 2–8°C; stable refrigerated for full shelf life, near-stable over 90 days at room temperature
Intended use Analytical grade · For research and analytics only · For export only
Documentation Batch-specific Certificate of Analysis
Retatride XS sachet label

HIGH-STRENGTH PRESENTATION

Retatride™ XS — 60 mg single-vial format

Retatride™ XS carries the same retatrutide peptide as the standard presentation, concentrated at 60 mg per vial for laboratories working at larger analytical scales. Each foil sachet holds a 1+1 configuration: one vial of lyophilised peptide paired with one companion vial.

XS is produced under the same Pressurized Dark-Room Fragmented Lyophilization process, batch documentation and cold-chain standards as every CoreyPauling product, with its own lot series and Certificate of Analysis.

FOR EXPORT ONLY FOR RESEARCH AND ANALYTICS ONLY

PRODUCT SPECIFICATIONS

Retatride™ XS at a glance

Product name Retatride™ XS
Active substance Retatrutide (identical peptide to standard Retatride™)
Strength 60 mg per vial
Form Lyophilised powder for reconstitution
Presentation Multi-dose glass vial
Pack size 1+1 vials per foil sachet
Origin Synthetic peptide built on a modified GIP backbone
Storage Store cold at 2–8°C; stable refrigerated for full shelf life, near-stable over 90 days at room temperature
Intended use Analytical grade · For research and analytics only · For export only
Documentation Batch-specific Certificate of Analysis

OUR TECHNOLOGY

Pressurized Dark-Room Fragmented Lyophilization

Retatride™ is lyophilised using CoreyPauling's proprietary Pressurized Dark-Room Fragmented Lyophilization process, which protects the peptide from light and oxidative stress during freeze-drying. The result is stability that conventional lyophilisates cannot match.

90+ days

Near-stable at room temperature

The lyophilised powder remains almost fully stable for over 90 days at room temperature — forgiving of transit delays and customs holds without loss of integrity.

3 years

Stable in cold storage

Stored cold at 2–8°C, Retatride™ retains full stability for the shelf life stated on every label, from the date of manufacture.

Retatride™ is analytical grade only. CoreyPauling does not encourage or support its use in humans or veterinary applications.

QUALITY & MANUFACTURING

Every batch documented

STD

International standards

Manufactured under internationally recognised quality standards with controlled environments and validated processes at every production step.

HPLC

Analytical verification

Identity, purity and content are verified by HPLC and complementary analytical methods before any batch is released.

LOT

Full traceability

Lot, manufacturing and expiry data are printed on every sachet and vial, tied to batch records and the Certificate of Analysis.

STORAGE & HANDLING

Cold chain, door to door

Store cold at 2–8°C

Keep refrigerated for full shelf life. Do not freeze. Protect vials from light and keep them in the original sachet until use; brief room-temperature excursions are tolerated thanks to our lyophilization process.

Insulated export shipping

Wholesale consignments ship in insulated packaging with cooling elements and temperature indicators, with export documentation prepared per destination.

FAQ

Frequently Asked Questions

Retatride™ is available exclusively through authorized retailers and distributors. Contact our wholesale team to be directed to an authorized retailer in your region.

No. CoreyPauling supplies wholesale quantities to distributors and authorized retailers only.

MOQ depends on destination and packaging configuration. Standard wholesale units are sachets of 10 vials; contact us with your required volume for tiered pricing.

Yes. Every batch ships with a batch-specific Certificate of Analysis covering identity, purity and content, referenced to the lot number printed on the sachet and vial labels.

Commercial invoice, packing list and Certificate of Analysis are standard. Additional documentation can be prepared according to the import requirements of the destination country.

CoreyPauling laboratory

ABOUT COREYPAULING

Science · Innovation · Quality · Trust

CoreyPauling is a US–Singapore based biotechnology company developing and supplying research-grade peptides and proteins to distributors and laboratories worldwide. Grounded in scientific rigour and international manufacturing standards, the brand stands for precision, continuous innovation and long-term reliability.

Retatride™ sits alongside the wider CoreyPauling catalogue — including Somapin™, Bepeci™, Menotan™ and Pregnil™ — all supplied under the same documentation and cold-chain standards.

Every batch of Retatride™ is manufactured at the CoreyPauling facility. Full company information, the complete product catalogue and manufacturing capabilities are available on the official factory website at coreypauling.com.

VISIT COREYPAULING.COM

WHOLESALE INQUIRY

Distribute Retatride™

For quotations, batch documentation, certificates of analysis and export terms, contact our wholesale team. Please include your company details, destination country and required quantities.

support@coreypauling.com
For Research and Analytics Only